ClinicalTrials.Veeva

Menu

Individualized Fortification of Human Milk for Infants Born ≤ 1250 g (MaxiMoM-InForM)

T

The Hospital for Sick Children

Status

Enrolling

Conditions

Very Low Birth Weight Infant

Treatments

Other: Target fortification
Other: BUN adjustable fortification
Other: Standard fortification

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Very low birth weight infants have increased nutritional needs. Extra nutrients are added to their human milk feeds to help improve their nutritional status, growth and neurodevelopment. Standard fortification of human milk is routine in most neonatal units in North America, but despite the added nutrients, infants are often discharged from hospitals with poor growth, and their neurodevelopment remains suboptimal. Two individualized fortification methods, target and BUN adjustable, have been proposed to improve the nutrient supply to infants. However, there is currently insufficient evidence to support the implementation of individualized fortification or one method over the other. Therefore, this study will randomly assign very low birth weight infants to receive feeds fortified according to standard, target or BUN adjustable fortification methods until 36 weeks gestational age or hospital discharge whichever occurs first. Feedings will be prepared in milk preparation rooms to ensure caregivers and outcomes assessor remain blinded to feeding allocation. Growth, morbidities, and nutrient intakes will be determined throughout hospitalization and skinfolds assessed at 36 weeks. At 4 months CA, growth and body composition will be determined by air displacement plethysmography and processing speed by electroencephalography on a subset of infants. Neurodevelopment will be assessed using the Bayley Scales of Infant and Toddler Development, at 18-24 months CA.

Enrollment

615 estimated patients

Sex

All

Ages

Under 21 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≤1250 g birth weight.
  • Parental/guardian consent to participate.
  • Consent for the use of pasteurized donor milk if mother's milk is not available.

Exclusion criteria

  • Infant received fortifier or formula before Study Day 1.
  • Study Day 1 to occur after day 21 of life.
  • Infants with congenital or chromosomal anomalies that may affect growth outcome.
  • Enrollment in any other clinical study affecting nutritional management during the feeding intervention.
  • Reasonable potential that the infant will be transferred to a NICU where the study protocol will not be continued.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

615 participants in 3 patient groups

Standard fortification
Active Comparator group
Treatment:
Other: Standard fortification
Target fortification
Experimental group
Treatment:
Other: Target fortification
BUN adjustable fortification
Experimental group
Treatment:
Other: BUN adjustable fortification

Trial contacts and locations

20

Loading...

Central trial contact

Deborah O'Connor, PhD RD; Sharon Unger, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems